[
  {
    "ts": null,
    "headline": "BD Gets FDA 510(k) Approval for EnCor EnCompass Breast Biopsy System",
    "summary": "BDX wins FDA 510(k) clearance for the EnCor EnCompass breast biopsy system, set for an early 2026 launch to boost flexibility and patient care.",
    "url": "https://finnhub.io/api/news?id=bc239500a396d0c504bcfe9c67d3ca3e52fde1923a2112da5857b46a8329c9ce",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769013780,
      "headline": "BD Gets FDA 510(k) Approval for EnCor EnCompass Breast Biopsy System",
      "id": 138198293,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "BDX wins FDA 510(k) clearance for the EnCor EnCompass breast biopsy system, set for an early 2026 launch to boost flexibility and patient care.",
      "url": "https://finnhub.io/api/news?id=bc239500a396d0c504bcfe9c67d3ca3e52fde1923a2112da5857b46a8329c9ce"
    }
  },
  {
    "ts": null,
    "headline": "BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market",
    "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Ypsomed, a leading developer of injection systems, are strengthening their collaboration with the development of a 5.5 mL version of the BD Neopak™ XtraFlow™ Glass Prefillable Syringe. This innovation is designed to be fully compatible with Ypsomed's YpsoMate® 5.5 autoinjector platform, expanding options for pharmaceutical companies and patients who require large‑volume subcutaneous self‑injections.",
    "url": "https://finnhub.io/api/news?id=f3a932a70979d8f3ccb8f0643d678852458dffaea073cf3db61d4202b3e525e0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768996200,
      "headline": "BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market",
      "id": 138194483,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Ypsomed, a leading developer of injection systems, are strengthening their collaboration with the development of a 5.5 mL version of the BD Neopak™ XtraFlow™ Glass Prefillable Syringe. This innovation is designed to be fully compatible with Ypsomed's YpsoMate® 5.5 autoinjector platform, expanding options for pharmaceutical companies and patients who require large‑volume subcutaneous self‑injections.",
      "url": "https://finnhub.io/api/news?id=f3a932a70979d8f3ccb8f0643d678852458dffaea073cf3db61d4202b3e525e0"
    }
  }
]